MotivaImplants® MotivaImagine® Careers

Investors

Press Releases

Press Releases

September 20, 2022
Establishment Labs to Host Investor Event for Mia Femtech on October 5, 2022
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Sep. 20, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that it will host an investor event on October 5, 2022 to
Read More
September 12, 2022
Establishment Labs Announces Hani Zeini has Joined the Company as Exclusive Advisor in Anticipation of US Launch
Hani Zeini is a 20+ year executive in the breast aesthetics industry, including as CEO and Founder of Sientra SANTA BARBARA, Calif. --(BUSINESS WIRE)--Sep. 12, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast
Read More
August 8, 2022
Establishment Labs Reports Record Second Quarter 2022 Financial Results
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Aug. 8, 2022-- Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second
Read More
August 3, 2022
Establishment Labs Announces Complete Enrollment in Motiva US IDE Study
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Aug. 3, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has completed enrollment in the
Read More
July 25, 2022
Establishment Labs to Announce Second Quarter 2022 Financial Results on August 8
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 25, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the
Read More
July 19, 2022
Establishment Labs Releases 2021 Sustainability Review
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 19, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced publication of its 2021
Read More
June 6, 2022
Establishment Labs to Present at the Jefferies Healthcare Conference
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jun. 6, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder
Read More
May 9, 2022
Establishment Labs Reports Record First Quarter 2022 Financial Results
SANTA BARBARA, Calif. --(BUSINESS WIRE)--May 9, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first
Read More
April 28, 2022
Establishment Labs to Announce First Quarter 2022 Financial Results on May 9
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Apr. 28, 2022-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the
Read More
April 26, 2022
Establishment Labs Enters Into $225 Million Credit Facility With Oaktree
- Senior secured term loan of up to $225 million , with a $150 million initial draw and $75 million available on achievement of commercial and regulatory milestones - Facility provides non-dilutive capital to fund Establishment Labs to cash flow positive under current estimates SANTA BARBARA,
Read More
Displaying 1 - 10 of 18